Darryl Geddes 315 464-4828
SUNY Upstate drug study seeks patients with Crohn’s disease
SYRACUSE, N.Y. – SUNY Upstate Medical University is seeking individuals with Crohn’s disease for a study testing the efficacy of the drug Leukine. Currently used in preventing infection in certain types of cancer therapy, Leukine helps stimulate immune cells that may be helpful in strengthening the immune system of the intestine.
The study seeks individuals over the age of 18 who have been diagnosed with moderate to severe Crohn’s disease. Subjects can be taking Mesalamine drugs, but cannot be on steroids or other immunosuppressants.
Crohn’s disease is a chronic inflammatory disease of the intestines. It primarily causes ulcerations in the small and large intestines, but can affect the digestive system anywhere between the mouth and the anus. Diarrhea, rectal bleeding and abdominal pain are frequent symptoms of Crohn’s disease.
For more information on the study, contact Kathy Moore at 464-9077.
Search Upstate News
Upstate in the News
- New York Teen Donates Kidney to Younger Brother: 'This Was My Chance to Save Him'
- Syracuse teen receives kidney transplant from older brother
WTVH CBS5 Syracuse
- Inside the Mind of the Munich Mass Killer
- How 'Determined Danielle' became president of Upstate Medical University
Syracuse Post Standard
- BRCA Gene Mutations May Influence Prostate Cancer Risk
Renal and Urology News
- Upstate Medical to use nearly $200,000 in NSF funding to fight Zika virus
Central New York Business Journal